Golden Star Receives New Shipment of NA Drones for Mass Marketing Campaign

July 15, 2015 9:40 AM EDT | Source: Golden Star Enterprises Ltd.

New York, New York--(Newsfile Corp. - July 15, 2015) - Golden Star Enterprises Ltd. (OTC Pink: GSPT) reports that the Company has received a new shipment of NA Drones for an online mass marketing campaign. The Company has several affiliate programs targeting the specific sale of X-factors and Kaspers, two of the more popular drone models suitable for the average consumer and extreme sports enthusiasts respectively. Specifications on X-factor and Kasper drones can be found at www.nadrone.com.

Matt Kelly, Director of Golden Star Enterprises Ltd. states, "leading brands such as DJI, a well known drone company puts heavy focus on online sales as most drones are currently being purchased online. With support of social media marketing NA Drones seeks to expand its brand foot print in the industry through the already proven online sales channels."

In addition, the Company will continue its business to business presence in trade shows all over North America to grow its brand of drone products. Golden Star expects the consumer base for the easy to maneuver NA Drones to grow as word of mouth for the quality and value of the products are known to wholesalers as well as retailers and consumers.

NA Drones has an exclusive co-branding, distribution agreement in place with one of the top drone makers in the world (manufacturer of "Ghost" drones) to sell co-branded drones throughout North America.

More information about NA Drones can be found on website www.nadrone.com.
For further information contact: 1-888-488-6882

/s/ Matt Kelly
Matt Kelly, Director
***

Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995: The statements contained herein which are not historical fact are forward-looking statements that are subject to risks and uncertainties that could cause actual results to differ materially from those expressed in the forward-looking statements, including, but not limited to, certain delays in testing and evaluation of products and other risks detailed from time to time in Golden Star's filings with OTC Markets.

info